• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Model Number GBF0508
Device Problems Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Foreign Body Reaction (1868)
Event Date 09/01/2016
Event Type  Injury  
Manufacturer Narrative
The patient was injected with the product on two different occasions in the same areas: the most recent was with bellafill dermal filler ((b)(4)), lot f151077, in (b)(6) 2015 (exact date unknown).The prior injection was with artefill dermal filler ((b)(4), artefill is the prior brand name), lot f141032, on (b)(6) 2015.Suneva conducted a lot review of a both lots.No issues were found with either lot.The lots were manufactured in accordance with approved work instructions and met acceptance criteria at time of product release.Retained lot samples were also reviewed and the lots continue to meet release criteria.The doctor originally reported nodules on (b)(6) 2016 which were being successfully treated with kenalog, 5fu, and collagenase.The "wood tissue changes" were added by the doctor on (b)(6) 2017.On (b)(6) 2017, the doctor relayed that the "woody tissue changes" were disfiguring and were only improving with multiple treatment injections.The patient was injected in both on-label and off-label locations and had nodules in all areas; however it is not clear at this time where the described "woody tissue changes" were located: on-label: nasolabial folds; off-label: brow, peri-oral areas, and under the eyes.The bellafill injector is aware of bellafill indications.
 
Event Description
Patient ((b)(6)) was injected with bellafill dermal filler (and artefill dermal filler - prior brand name) in the brows, nasolabial folds, peri-oral area, and under the eyes on (b)(6) 2015 and in (b)(6) 2015 (exact date not provided).On (b)(6) 2017 the doctor reported what he described as "woody tissue changes." on (b)(6) 2017, the doctor added that the "woody tissue changes" are disfiguring and are only improving with multiple "dissolving" injections of kenalog, 5fu, and collagenase.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BELLAFILL DERMAL FILLER
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer (Section G)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer Contact
stacy lewis
5870 pacific center blvd.
san diego, CA 92121
8585509999
MDR Report Key6375143
MDR Text Key68967995
Report Number3003707320-2017-00006
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date11/26/2016
Device Model NumberGBF0508
Device Catalogue NumberGBF0508
Device Lot NumberF151077
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ARTEFILL DERMAL FILLER
Patient Outcome(s) Required Intervention;
-
-